Holen Sie sich die Stockscreener-App
3.56
3.78%
-0.14
Schlusskurs vom Vortag:
$3.70
Offen:
$3.73
24-Stunden-Volumen:
263.45K
Relative Volume:
0.67
Marktkapitalisierung:
$42.59M
Einnahmen:
$12,000
Nettoeinkommen (Verlust:
$-48.50M
KGV:
-0.2086
EPS:
-17.0687
Netto-Cashflow:
$-19.78M
1W Leistung:
-6.81%
1M Leistung:
-6.07%
6M Leistung:
-70.12%
1J Leistung:
-46.91%
1-Tages-Spanne:
$3.43
$3.79
1-Wochen-Bereich:
$3.43
$4.17
52-Wochen-Spanne:
$2.49
$49.80
Incannex Healthcare Inc Stock (IXHL) Company Profile
Firmenname
Incannex Healthcare Inc
Sektor
Telefon
61 409 840 786
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
3.56 | 42.59M | 12,000 | -48.50M | -19.78M | -17.07 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten
Why Did IXHL Stock Tank Over 32% Today? - Stocktwits
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
Incannex Healthcare Inc (IXHL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incannex Healthcare Inc (IXHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Incannex Healthcare Inc (IXHL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IXHL Forecast — Price Target — Prediction for 2027 - TradingView
IXHL Should I Buy - Intellectia AI
$Incannex Healthcare (IXHL.US)$ - Moomoo
Incannex Healthcare receives A$6m R&D tax incentive payment - Investing.com UK
Incannex Healthcare receives A$6m R&D tax incentive payment By Investing.com - Investing.com Nigeria
Incannex Healthcare Secures Major Non-Dilutive R&D Funding - TipRanks
Incannex Healthcare Secures Over A$11 Million in Non-Dilutive Capital Through Australian R&D Tax Incentive Program - Quiver Quantitative
Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility - The Manila Times
Incannex lines up A$11m in non‑dilutive cash to advance IHL‑42X study - Stock Titan
Incannex Receives A$6.0M R&D Tax Refund, Expects A$11.1M+ in Non-Dilutive Funding - TradingView
Incannex (Nasdaq: IXHL) secures over A$11.1M in R&D tax incentives - Stock Titan
Incannex Healthcare: Target Price Consensus and Analysts Recommendations | IQI | AU000000IHL8 - marketscreener.com
Incannex Healthcare Gains Independent Buy-Rated Research Coverage - TipRanks
Sleep apnea and anxiety drug developer Incannex gets AGP buy rating at $18 - Stock Titan
Incannex Healthcare: Alliance Global Partners Starts Coverage with $18 Price Target - TradingView
Alliance Global initiates Incannex (IXHL) equity research coverage on key drug pipeline - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
$Incannex Healthcare (IXHL.US)$ [Onlooker][OK] - Moomoo
INCANNEX HEALTHCARE INC (IXHL) Stock Chart - ChartMill
Incannex Healthcare Q1 2026 Earnings: Deep EPS Miss Reflects Heavy R&D InvestmentOperating Income Trends - newsline.com
Why Are ASX Cannabis Stocks Drawing Fresh Attention? - Kalkine Media
IXHL Q1 2026 Earnings: Massive EPS Miss as Clinical-Stage Biotech Reports Wider-Than-Expected LossProfit Announcement - newsline.com
Incannex Healthcare (IXHL) Dips 3.27% as Stock Tests Near-Term SupportCall Wall - newsline.com
Incannex Healthcare | 8-K: Current report - Moomoo
Incannex Shares Surge Following Promising Sleep Apnea Trial Data - MSN
Incannex reactivates share repurchase program, cites ‘significant disconnect’ between its market cap and financial strength - MSN
IXHL Technical Analysis | Trend, Signals & Chart Patterns | INCANNEX HEALTHCARE INC (NASDAQ:IXHL) - ChartMill
Incannex Healthcare Commences DReAMzz Clinical Study for IHL-42X in OSA - Sleep Review
Incannex Healthcare Inc. 1Q 2026: Revenue $0.09M, EPS $(0.35) — 10-Q Summary - TradingView
IXHL: Cash rose to $74.5M, net loss reached $16.8M, and $9.1M was spent on share repurchases - TradingView
Incannex Healthcare (NASDAQ: IXHL) grows cash to $74.5M amid $16.8M loss - Stock Titan
Incannex Healthcare Commences DReAMzz Clinical Study Of IHL-42X For Obstructive Sleep Apnea - TradingView
Incannex launches DReAMzz study for sleep apnea treatment - Investing.com UK
Incannex Healthcare Launches DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea, Advancing Late-Stage Development 1 - Minichart
Incannex launches DReAMzz study for sleep apnea treatment By Investing.com - Investing.com South Africa
Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.23%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):